A shot to save the world The inside story of the life-or-death race for a Covid-19 vaccine

Wall Street Journal reporter Zuckerman traces the seemingly miraculous development of the Covid vaccine in this captivating account (after The Man Who Solved the Market). Through interviews with "scientists, academics, executives, government officials, investors, and others," Zuckerman makes a case that the creation of the vaccine was the result of "years of dedication, creativity, and frustration." He introduces a slew of scientists past and present whose work, in one way or another, impacted the efforts to cure Covid: there's Gale Smith, a molecular biologist who "theorized that insect viruses could be used to infect insect cells to produce specific proteins" in the 1980s; Frank Volvovitz, who started a company called MicroGeneSys to pursue a vaccine for AIDS; Jon Wolff, who was a key player in mRNA research; and Moderna scientist Eric Huang, who advised the company that they should be "making vaccines, not drugs" in 2013. Things move at a fast clip as Zuckerman conveys decades of complex scientific research in a gripping fashion. His focus on the slow burn of discovery makes for a fascinating angle and offers plenty of inspiration: "The Covid-19 vaccine story is one of heroism, dedication, and remarkable persistence." The result is tough to put down. (Oct.)

Not the first but a thorough, journalistic history of viral vaccines culminating with Covid-19: a spectacular achievement in which entrepreneurs played as great a role as scientists. Zuckerman, Special Writer at the Wall Street Journal, recounts the lives of brilliant researchers, but he gives equal space to drug companies, both established (Merck, Pfizer) and fairly new (Moderna, Novavax). Not charitable institutions, they give vaccines a low priority because there is little profit in them. It's more lucrative to sell medicine taken daily for life. Drug companies perk up when governments spend money, so their responses to AIDS, MERS, SARS, and Ebola--all viral epidemics--were swift and large in scale. But nothing matched the response to the devastating Covid-19 pandemic. Zuckerman describes the massive investment, research, and testing that produced effective vaccines that have so far saved hundreds of thousands of lives and prevented at least 1.25 million additional hospitalizations. The author emphasizes that this was a dazzling advance because the average vaccine took 10 years to produce. The fastest was mumps, which took four; developing Covid vaccines took one. Rewinding the clock to 1979, Zuckerman describes the onset of the AIDS epidemic and the ongoing, still unsuccessful efforts to produce a vaccine for HIV. Moving steadily toward the present, the author delivers interesting capsule biographies of fiercely workaholic scientists and tireless promoters seeking to commercialize their ideas in the battle against subsequent epidemics. Readers will learn a great deal, perhaps more than they want to know, about vaccine science even before Covid makes its appearance more than halfway through the narrative. Thereafter, Zuckerman offers a blow-by-blow account of the cutting-edge technology and maddening politics that led to effective vaccines in record time. He carries his story to summer 2021, when the virus staged a vicious comeback and researchers scrambled for solutions. While not certain, it's possible that Covid will not be eliminated like smallpox but remain as a seasonal disease like influenza. An intensely researched, rewarding account of an impressive medical triumph. Copyright (c) Kirkus Reviews, used with permission.